-+ 0.00%
-+ 0.00%
-+ 0.00%

Yibai Pharmaceutical (600594.SH): Compound cantharb capsules, etc. to be selected for centralized procurement

Zhitongcaijing·08/03/2026 13:57:01
Listen to the news

Zhitong Finance App News, Yibai Pharmaceutical (600594.SH) announced that the company recently participated in the bidding process for centralized procurement of the National Proprietary Chinese Medicine Procurement Alliance (second batch continuation). According to the “Notice Concerning Announcing the Supply List of Selected Varieties Selected from the National Proprietary Chinese Medicine Procurement Alliance” recently issued by the National Proprietary Chinese Medicine Joint Procurement Office, the company's products were selected for further procurement.

During the procurement cycle, medical institutions will prioritize the use of selected drugs in this successive procurement and ensure that the agreed purchase volume is completed. If the company subsequently signs a procurement contract and implements it, it will help further expand the sales scope of the selected products, increase the market share of the selected products, enhance the company's brand influence, and have a positive impact on the company's long-term development.